Texas Diabetes Institute is a clinical research site located in San Antonio, Texas, United States 78284.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
Texas Diabetes Institute has participated in 14 clinical trials with 4 currently active.
Therapeutic areas: Obesity, Overweight, Type 2 Diabetes Mellitus.
Sponsors: Amgen, Boehringer Ingelheim, Novo Nordisk A/S.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Texas Diabetes Institute has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Diabetes Institute has 14 clinical trials on record, with 4 currently active. Their work covers Obesity, Overweight, Type 2 Diabetes Mellitus.
Yes — Texas Diabetes Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.